Cargando…

Enoxaparin for primary thromboprophylaxis in ambulatory patients with coronavirus disease-2019 (the OVID study): a structured summary of a study protocol for a randomized controlled trial

OBJECTIVES: The OVID study will demonstrate whether prophylactic-dose enoxaparin improves survival and reduces hospitalizations in symptomatic ambulatory patients aged 50 or older diagnosed with COVID-19, a novel viral disease characterized by severe systemic, pulmonary, and vessel inflammation and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Barco, Stefano, Bingisser, Roland, Colucci, Giuseppe, Frenk, André, Gerber, Bernhard, Held, Ulrike, Mach, Francois, Mazzolai, Lucia, Righini, Marc, Rosemann, Thomas, Sebastian, Tim, Spescha, Rebecca, Stortecky, Stefan, Windecker, Stephan, Kucher, Nils
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7479300/ https://www.ncbi.nlm.nih.gov/pubmed/32907635 http://dx.doi.org/10.1186/s13063-020-04678-4

Ejemplares similares

Enoxaparin for primary thromboprophylaxis in symptomatic outpatients with COVID-19 (OVID): a randomised, open-label, parallel-group, multicentre, phase 3 trial
por: Barco, Stefano, et al.
Publicado: (2022)

Enoxaparin for outpatients with COVID-19: 90-day results from the randomised, open-label, parallel-group, multinational, phase III OVID trial
por: Voci, Davide, et al.
Publicado: (2023)

Ovid Discovery
por: Lilly, Jason A., et al.
Publicado: (2020)

Enoxaparin 20 mg for thromboprophylaxis in severe renal impairment
por: Karaoui, Lamis R., et al.
Publicado: (2018)

Outcomes of thromboprophylaxis with enoxaparin vs. unfractionated heparin in medical inpatients
por: McGarry, Lisa J, et al.
Publicado: (2006)

Bibliotherapy: Reading OVID During COVID
por: Stip, Emmanuel, et al.
Publicado: (2020)

Effectiveness, safety, and costs of thromboprophylaxis with enoxaparin or unfractionated heparin in inpatients with obesity
por: Amin, Alpesh, et al.
Publicado: (2023)

Major adverse limb events in patients with femoro-popliteal and below-the-knee peripheral arterial disease treated with either sirolimus-coated balloon or standard uncoated balloon angioplasty: a structured protocol summary of the “SirPAD” randomized controlled trial
por: Barco, Stefano, et al.
Publicado: (2022)

Postoperative decreased levels of D-dimer in patients with gynecologic cancer with enoxaparin and fondaparinux thromboprophylaxis
por: KODAMA, JUNICHI, et al.
Publicado: (2013)

Bemiparin versus enoxaparin as thromboprophylaxis following vaginal and abdominal deliveries: a prospective clinical trial
por: Alalaf, Shahla K, et al.
Publicado: (2015)

Case report: Successful thromboprophylaxis with enoxaparin in a pregnant woman with internal jugular vein agenesis
por: Di Micco, Pierpaolo, et al.
Publicado: (2022)

Effects of thromboprophylaxis on mesenchymal stromal cells during osteogenic differentiation: an in-vitro study comparing enoxaparin with rivaroxaban
por: Pilge, Hakan, et al.
Publicado: (2016)

Comparison of Postoperative Bleeding in Total Hip and Knee Arthroplasty Patients Receiving Rivaroxaban, Enoxaparin, or Aspirin for Thromboprophylaxis
por: Lindquist, Desirae E., et al.
Publicado: (2018)

Comparison of efficiency and safety of rivaroxaban, apixaban and enoxaparin for thromboprophylaxis after arthroplastic surgery: a meta-analysis
por: Yu, Zhi, et al.
Publicado: (2018)

Comparison of Anti-factor Xa Levels in Female and Male Patients with Obesity After Enoxaparin Application for Thromboprophylaxis
por: Wagner, Jonas, et al.
Publicado: (2022)

Comparison of the Efficacy and Safety of Rivaroxaban and Enoxaparin as Thromboprophylaxis Agents for Orthopedic Surgery—Systematic Review and Meta-Analysis
por: Rinaldi, Ikhwan, et al.
Publicado: (2022)

Modelling and predicting the spatio-temporal spread of cOVID-19 in Italy
por: Giuliani, Diego, et al.
Publicado: (2020)

Antifactor Xa Levels in Critically Ill Korean Patients Receiving Enoxaparin for Thromboprophylaxis: A Prospective Observational Study
por: Lim, So Yeon, et al.
Publicado: (2013)

Primary Thromboprophylaxis in Ambulatory Cancer Patients: Where Do We Stand?
por: Mulder, Frits I., et al.
Publicado: (2020)

Standard- versus intermediate-dose enoxaparin for anti-factor Xa guided thromboprophylaxis in critically ill patients with COVID-19
por: Hamilton, David Oliver, et al.
Publicado: (2021)

Efficacy and Safety of Two Different Enoxaparin Doses for Thromboprophylaxis in Non-critically Ill Patients: A Randomized Controlled Trial
por: Alavi-Darazam, Ilad, et al.
Publicado: (2022)

Development and evaluation of a search filter to identify prognostic factor studies in Ovid MEDLINE
por: Stallings, Elena, et al.
Publicado: (2022)

A comparative study of varying doses of enoxaparin for thromboprophylaxis in critically ill patients: a double-blinded, randomised controlled trial
por: Robinson, Sian, et al.
Publicado: (2013)

Thromboprophylaxis with unilateral pneumatic device led to less edema and blood loss compared to enoxaparin after knee arthroplasty: randomized trial
por: Maradei-Pereira, João Alberto Ramos, et al.
Publicado: (2022)

Glomerular disease search filters for Pubmed, Ovid Medline, and Embase: a development and validation study
por: Hildebrand, Ainslie M, et al.
Publicado: (2012)

Type of anaesthesia and the safety and efficacy of thromboprophylaxis with enoxaparin or dabigatran etexilate in major orthopaedic surgery: pooled analysis of three randomized controlled trials
por: Rosencher, Nadia, et al.
Publicado: (2012)

Thromboprophylaxis with enoxaparin is associated with a lower death rate in patients hospitalized with SARS-CoV-2 infection. A cohort study
por: Albani, Filippo, et al.
Publicado: (2020)

Anti-factor Xa Activity Is Not Associated With Venous Thromboembolism in Critically Ill Patients Receiving Enoxaparin for Thromboprophylaxis: A Retrospective Observational Study
por: Dibiasi, Christoph, et al.
Publicado: (2022)

Underuse of medical thromboprophylaxis in mobile elderly inpatients: The SWITCO65+ cohort
por: Blondon, Marc, et al.
Publicado: (2020)

Locating sex-specific evidence on clinical questions in MEDLINE: a search filter for use on OvidSP™
por: Moerman, Clara J, et al.
Publicado: (2009)

A failed attempt at developing a search filter for systematic review methodology articles in Ovid Embase
por: Neilson, Christine, et al.
Publicado: (2019)

The NICE OECD countries' geographic search filters: Part 2—validation of the MEDLINE and Embase (Ovid) filters
por: Ayiku, Lynda, et al.
Publicado: (2021)

Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons
por: Gómez-Outes, Antonio, et al.
Publicado: (2012)

Rivaroxaban Versus Enoxaparin for Thromboprophylaxis After major Gynecological Cancer Surgery: The VALERIA Trial: Venous thromboembolism prophylAxis after gynecoLogical pElvic cancer surgery with RIvaroxaban versus enoxAparin (VALERIA trial)
por: Longo de Oliveira, André Luiz Malavasi, et al.
Publicado: (2022)

Cost–utility analysis of apixaban compared with usual care for primary thromboprophylaxis in ambulatory patients with cancer
por: Kimpton, Miriam, et al.
Publicado: (2021)

Thromboembolic events in COVID-19 ambulatory patients: An observational study about incidence, and thromboprophylaxis outcomes
por: Hammami, Rania, et al.
Publicado: (2022)

A multi-perspective cost-effectiveness analysis comparing rivaroxaban with enoxaparin sodium for thromboprophylaxis after total hip and knee replacement in the German healthcare setting
por: Zindel, Sonja, et al.
Publicado: (2012)

The NICE OECD countries’ geographic search filters: Part 1—methodology for developing the draft MEDLINE and Embase (Ovid) filters
por: Ayiku, Lynda, et al.
Publicado: (2021)

Telemedical Consultations in Palliative Care: Benefits through Knowledge Exchange and Intercollegiate Collaboration—Findings from the German oVID Project
por: Bückmann, Andreas, et al.
Publicado: (2023)

In-hospital fatality and venous thromboembolism during the first and second COVID-19 waves at a center opting for standard-dose thromboprophylaxis
por: Mumoli, Nicola, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_rrbpc5q7353nr667d10djjc88h